Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felipe Ades

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression DataIvana Bozovic-Spasojevic, Dimitrios Zardavas, Sylvain Brohée, et al.
Breast (Edinburgh, Scotland)|September 23, 2023
Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8Guy Jerusalem, Aleix Prat, Roberto Salgado, et al.
Journal of Chemotherapy (Florence, Italy)|August 3, 2013
Comparison of a gene expression profiling strategy to standard clinical work-up for determination of tumour origin in cancer of unknown primary (CUP)Felipe Ades, Evandro de Azambuja, Gedske Daugaard, et al.
JCO Global Oncology|April 6, 2021
OncoAlert Round Table Discussions: The Global COVID-19 ExperienceGilberto Morgan, Evandro de Azambuja, Kevin Punie, et al.
Oncotarget|September 4, 2015
Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancerCarlo Palmieri, Iain Rj Macpherson, Kelvin Yan, et al.
Oncology and Therapy|August 5, 2020
Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 MonthsBegoña de Las Heras, Kamal S Saini, Frances Boyle, et al.
Future Oncology (London, England)|October 8, 2025
Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trialSherene Loi, Roberto Salgado, Giuseppe Curigliano, et al.
Nature Medicine|January 21, 2025
Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trialSherene Loi, Roberto Salgado, Giuseppe Curigliano, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression DataIvana Bozovic-Spasojevic, Dimitrios Zardavas, Sylvain Brohée, et al.
Breast (Edinburgh, Scotland)|September 23, 2023
Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8Guy Jerusalem, Aleix Prat, Roberto Salgado, et al.
Journal of Chemotherapy (Florence, Italy)|August 3, 2013
Comparison of a gene expression profiling strategy to standard clinical work-up for determination of tumour origin in cancer of unknown primary (CUP)Felipe Ades, Evandro de Azambuja, Gedske Daugaard, et al.
JCO Global Oncology|April 6, 2021
OncoAlert Round Table Discussions: The Global COVID-19 ExperienceGilberto Morgan, Evandro de Azambuja, Kevin Punie, et al.
Oncotarget|September 4, 2015
Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancerCarlo Palmieri, Iain Rj Macpherson, Kelvin Yan, et al.
Oncology and Therapy|August 5, 2020
Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 MonthsBegoña de Las Heras, Kamal S Saini, Frances Boyle, et al.
Future Oncology (London, England)|October 8, 2025
Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trialSherene Loi, Roberto Salgado, Giuseppe Curigliano, et al.
Nature Medicine|January 21, 2025
Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trialSherene Loi, Roberto Salgado, Giuseppe Curigliano, et al.
Pageof 3